Abstract:Background: The development of the capability and capacity to evaluate the outcomes of trials of complex interventions is a key priority of the National Institute for Health Research (NIHR) and the Medical Research Council (MRC). The evaluation of complex treatment programmes for mental illness (e.g. cognitive-behavioural therapy for depression or psychosis) not only is a vital component of this research in its own right but also provides a well-established model for the evaluation of complex interventions in other clinical areas. In the context of efficacy and mechanism evaluation (EME) there is a particular need for robust methods for making valid causal inference in explanatory analyses of the mechanisms of treatment-induced change in clinical outcomes in randomised clinical trials. Objectives: The key objective was to produce statistical methods to enable trial investigators to make valid causal inferences about the mechanisms of treatment-induced change in these clinical outcomes. The primary objective of this report is to disseminate this methodology, aiming specifically at trial practitioners. Methods: The three components of the research were (1) the extension of instrumental variable (IV) methods to latent growth curve models and growth mixture models for repeated-measures data; (2) the development of designs and regression methods for parallel trials; and (3) the evaluation of the sensitivity/robustness of findings to the assumptions necessary for model identifiability. We illustrate our methods with applications from psychological and psychosocial intervention trials, keeping the technical details to a minimum, leaving the reporting of the more theoretical and mathematically demanding results for publication in appropriate specialist journals. Results: We show how to estimate treatment effects and introduce methods for EME. We explain the use of IV methods and principal stratification to evaluate the role of putative treatment effect mediators and therapeutic process measures. These results are extended to the analysis of longitudinal data structures. We consider the design of EME trials. We focus on designs to create convincing IVs, bearing in mind assumptions needed to attain model identifiability. A key area of application that has become apparent during this work is the potential role of treatment moderators (predictive markers) in the evaluation of treatment effect mechanisms for personalised therapies (stratified medicine). We consider the role of targeted therapies and multiarm trials and the use of parallel trials to help elucidate the evaluation of mediators working in parallel. Conclusions: In order to demonstrate both efficacy and mechanism, it is necessary to (1) demonstrate a treatment effect on the primary (clinical) outcome, (2) demonstrate a treatment effect on the putative mediator (mechanism) and (3) demonstrate a causal effect from the mediator to the outcome. Appropriate regression models should be applied for (3) or alternative IV procedures, which account for unmeasured confounding, provided that a valid instrument can be identified. Stratified medicine may provide a setting where such instruments can be designed into the trial. This work could be extended by considering improved trial designs, sample size considerations and measurement properties. Funding: The project presents independent research funded under the MRC-NIHR Methodology Research Programme (grant reference G0900678).

Issues in the study design of large scale public health program evaluation

[The Use and Pitfalls of Large Randomized Controlled Trials].

Evaluating the Health Impact of Large-Scale Public Policy Changes: Classical and Novel Approaches

Comparing alternative design options for chronic disease prevention interventions

Strengthening causal inference from randomised controlled trials of complex interventions

Natural experiment methodology for research: a review of how different methods can support real-world research

A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results

Improving the Validity of Non-Interventional Comparative Effectiveness Research by Basing Study Design on a Specified Existing Randomised Controlled Trial

Why so many "rigorous" evaluations fail to identify unintended consequences of development programs: How mixed methods can contribute

Challenges in Evaluating a Community-Level Intervention to Address Root Causes of Youth Violence

Discussion on Evaluation Design of Community-based Health Promotion Programs

Evaluation and validation of social and psychological markers in randomised trials of complex interventions in mental health: a methodological research programme

Methodology for Evaluating a Partially Controlled Longitudinal Treatment Using Principal Stratification, With Application to a Needle Exchange Program

Assessing Methods for Generalizing Experimental Impact Estimates to Target Populations

Leveraging contact network structure in the design of cluster randomized trials

Estimating Causal Impacts of Scaling a Voluntary Policy Intervention

Study designs for extending causal inferences from a randomized trial to a target population

Randomization Bias in Field Trials to Evaluate Targeting Methods

[Progress in methodological research on bridging the efficacy-effectiveness gap of clinical interventions(2): to improve the extrapolation of efficacy]

Natural Experiments: An Overview of Methods, Approaches, and Contributions to Public Health Intervention Research